Fig. 2
Hepatoprotective effect of EAAC was assessed in vitro. a HepG2 Cell viability with different concentrations of EAAC was determined after 24 h incubation. b Recovered HepG2 cell viability against CCl4 by treatment of different concentrations of EAAC and silymarin. The culture media changed with FBS-free DMEM containing CCl4 (8 mM) for 2 h. * shows statistically significant differences at p < 0.05 from the CCl4 group and ** at p < 0.01